Claims / Legal
Chubb Estimates Q2 Cat Losses at $240M
The Chubb Corp. estimates that catastrophe losses in the second quarter will be approximately $240 million before tax, or $156 million after tax ($0.60 per share after tax). The company said that ...
Sandy Collector Auto Claims: A CEO’s Takeaways From The Nation’s 3rd-Worst Insurance Disaster
Superstorm Sandy made landfall October 29, 2012, crossing the coast of New Jersey and creating damage in a widespread path up and down the East Coast. Sandy, a post-tropical cyclone, caused more ...
Insured Damage from European Floods Will Near $3.8B, Says Munich Re
Flooding in Europe last month will cause more than 12 billion euros ($15.5 billion) of damage, the year's most expensive natural catastrophe, according to Munich Re, the world's biggest reinsurer. ...
AIG Said to Be Lead Insurer on Asiana Crash in San Francisco
American International Group Inc. was the lead insurer providing coverage for the Asiana Airlines Inc. jet that crashed while landing in San Francisco last weekend, according to two people familiar ...
Expecting The Unexpected: 5 Questions To Consider When Ramping Up Your CAT Staff
When disaster strikes, your organization's response is only as good as your workforce. Timing is everything and you need to be staffed for the unexpected. How can you assess your human capital ...
Countrywide Board, CEO Mozilo Should Face Investors’ Claims, Court Told
Former Countrywide Financial Corp. directors, including ex-Chief Executive Officer Angelo Mozilo, should be forced to face claims that they misled investors about the quality of the mortgage-lender's ...
New Jersey Utility Sues 11 Insurers Including AIG, Allianz, ACE Over Sandy Cover
Public Service Enterprise Group Inc., the largest provider of gas and electric service in New Jersey, sued 11 insurers, including American International Group Inc., over losses from Hurricane Sandy. ...
Drugmakers Search for Safer Painkillers Amid Opioid Abuse Epidemic
Backed by a U.S. campaign to slow abuse of prescription painkillers, drugmakers are devising new forms of the medicines that don't lead to misuse and new products that treat dependency in a bid to ...